Aurora Investment Counsel’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,644
Closed -$793K 121
2022
Q2
$793K Sell
1,644
-1,255
-43% -$621K 0.57% 101
2022
Q1
$1.42M Sell
2,899
-562
-16% -$257K 0.91% 50
2021
Q4
$1.6M Sell
3,461
-936
-21% -$394K 0.95% 37
2021
Q3
$1.64M Sell
4,397
-38
-0.9% -$14.4K 1.14% 22
2021
Q2
$1.69M Sell
4,435
-234
-5% -$89.4K 1.18% 17
2021
Q1
$1.68M Sell
4,669
-117
-2% -$37.6K 1.24% 20
2020
Q4
$1.54M Buy
4,786
+18
+0.4% +$5.52K 1.24% 22
2020
Q3
$1.57M Buy
+4,768
New +$1.28M 1.3% 15

Other funds holding ELV

Aurora Investment Counsel's ELV Position: Q3 2022 in Review

Aurora Investment Counsel sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 1,644 shares — an estimated $793K sold.

Aurora Investment Counsel first reported a position in ELV in Q3 2020 and held it in 8 quarters. The position peaked at $1.69M in Q2 2021. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Aurora Investment Counsel reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Aurora Investment Counsel sold 1,644 Elevance Health shares in Q3 2022, an estimated $793K.
  • Aurora Investment Counsel first reported a position in Elevance Health in Q3 2020 and held it in 8 quarters.
  • Aurora Investment Counsel's Elevance Health position peaked at $1.69M in Q2 2021.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Aurora Investment Counsel's 13F filing for Q3 2022, filed 23 Nov 2022.